Gerbes A L
Medizinische Klinik II, Klinikum Grosshadern, Universität München.
Z Gastroenterol. 1987 Oct;25(10):677-82.
In the diagnosis of malignant ascites the cytological examination of ascitic fluid lacks sensitivity. Therefore, other parameters for the differentiation of malignant and hepatic ascites are needed. Determination of ascitic fluid cholesterol or fibronectin is superior to the traditional protein measurement in the differential diagnosis of ascites. In the therapy of cirrhotic ascites, physical maneuvers as well as dietary sodium and water restriction have long been known. Diuretic therapy, fraught with considerable side effects, has been applied to cirrhotics with ascites for more than 30 years. However, efficacy of only few regimens has been proven by randomized studies. Recently developed diuretics as well as the novel hormone Atrial Natriuretic Factor might bring about therapeutic advances. Paracentesis combined with intravenous albumin infusion might be reconsidered in severe ascites. Refractory ascites may be treated by implantation of peritoneo-venous shunts.
在恶性腹水的诊断中,腹水的细胞学检查缺乏敏感性。因此,需要其他参数来鉴别恶性腹水和肝性腹水。在腹水的鉴别诊断中,测定腹水胆固醇或纤维连接蛋白优于传统的蛋白测量。在肝硬化腹水的治疗中,物理手段以及饮食中钠和水的限制早已为人所知。利尿剂治疗存在相当多的副作用,已应用于肝硬化腹水患者30多年。然而,只有少数方案的疗效得到了随机研究的证实。最近开发的利尿剂以及新型激素心房利钠因子可能带来治疗进展。对于严重腹水,可重新考虑腹腔穿刺术联合静脉输注白蛋白。顽固性腹水可通过植入腹腔-静脉分流管进行治疗。